CannaMed Corporation Names Industry Veteran Paul Shively as Chief Financial Officer
LOS ANGELES, May 12, 2014 /PRNewswire/ — CannaMed Corp. (OTCBB: MDMJ), an entity that provides through a wholly-owned subsidiary both turnkey support services for the legal cannabis industry and secured loans to select industry participants seeking to acquire agricultural, industrial, and retail real estate, is pleased to announce the addition of Mr. Paul Shively as Chief Financial Officer.
Mr. Shively holds a Doctorate in Education and has considerable expertise in business development, fiscal management and corporate compliance. Throughout his more than 26 years of practical experience in business development, Mr. Shively has helped over 500 legal cannabis industry participants develop as business entities. Mr. Shively’s diverse business background includes a private practice in accounting and corporate compliance, and for the last ten years he has served on the board of over a dozen non-profit and for profit entities. He is also a recognized expert witness in the Los Angeles Superior Court system and is often asked by leading Los Angeles medical marijuana attorneys to assist in case preparation.
Mr. Shively also has vast experience in taxation, non-profit strategies, trademarks, corporate compliance and business acquisitions. His experience in sales tax administration has resulted in two successful Administrative Court decisions that resulted in changes in sales tax collection.
“We are pleased to add an executive of Mr. Shively’s caliber to our growing management team,” said Jordan Shapiro, Chief Executive Officer, of CannaMed Corp. “Paul’s diverse business background, especially in finance and business development is the skill-set we most sought for the tremendous opportunity ahead in legal cannabis. We look forward to his leadership and assistance in providing the market with the highest degree of financial transparency that this fully-reporting company can provide.”
“I look forward to contributing to the execution of CannaMed’s business model and to providing guidance to the team and its valued shareholders,” stated Shively. “I am passionate about this industry and look forward to participating in what I view is a tremendous opportunity in legal cannabis.”
For more information on CannaMed Corp visit www.cannamedcorp.com
About CannaMed Corporation
CannaMed Corporation, through a wholly-owned subsidiary, provides turnkey support solutions to the rapidly evolving and growing legal cannabis industry. CannaMed’s “seed to sale” key business services include:
-- Loans to duly licensed industry participants seeking to acquire agricultural, commercial, and retail real estate. -- Point of Sale (POS) credit and debit card processing -- Turnkey dispensary solutions -- Compliance consulting -- Financial services
CannaMed’s team has over seven years of successful experience in the legal cannabis industry. CannaMed is excited to introduce its array of services to each new state that legalizes cannabis use.
Safe Harbor Statement
This release contains “forward-looking statements” that include information related to future events and future financial and operating performance. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the ability of CannaMed to secure appropriate funding to implement its business plan, the demand for CannaMed’s services, CannaMed’s ability to maintain customer and strategic business relationships, the regulation of legal cannabis on both state and federal levels, the impact of competitive products and pricing, growth in targeted markets, and other information that may be detailed from time-to-time in CannaMed’s filings with the United States Securities and Exchange Commission. CannaMed undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE CannaMed Corporation